EXCEL-II DES to Treat the Patients With de Novo Coronary Artery Lesions. (CREDIT-III)

CompletedOBSERVATIONAL
Enrollment

625

Participants

Timeline

Start Date

January 8, 2014

Primary Completion Date

July 30, 2017

Study Completion Date

November 7, 2019

Conditions
Coronary Artery Disease
Interventions
DEVICE

EXCEL-II biodegradable polymer sirolimus-eluting stent

EXCEL-II biodegradable polymer sirolimus-eluting stent implantation

Trial Locations (1)

110015

Shenyang Northern Hospital, Shenyang

Sponsors
All Listed Sponsors
lead

JW Medical Systems Ltd

INDUSTRY